Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Flow Reactors

By Drug Discovery Trends Editor | October 16, 2012

FlowSyn from UniqsisThe FlowSyn range of integrated, flow reactor systems from Uniqsis Ltd. has been designed to handle a range of applications from homogeneous single reactions to complex, multi-reagent reactions. Optional gas addition, microwave, and low temperature and binary pump (4-channel) modules further enhance the operational versatility of the system.

Flow chemistry in micro-reactors has many advantages over batch processing notably better reproducibility and scalability, improved yields and fewer problems with unstable intermediates or exothermic reactions.

The system is available with the widest range of reactors (2 – 60 ml) in a choice of inert materials including stainless steel, Hastelloy, PFA, PTFE or copper.  Reactions requiring the use of strong acids such as nitric acid (nitrations) and organometallic bases such as butyl lithium are possible. A unique 2- or 3-channel borosilicate glass mixer chip reactor enables the system to undertake high throughput applications, fast mixing dependent reactions, and highly exothermic reactions requiring temperature control.

Two high pressure pumps operating at up to 100 bar (1,400 psi) deliver reagents, via a mixer, into electrically heated flow reactors. Back pressure regulators pressurize the system, allowing solvents to be superheated to a maximum of 260 C. 

Reaction outputs from the FlowSyn system can be fractionated or optimized at steady state, after which the system automatically flushes itself ready for the next experiment. The process is controlled using an integrated control interface.

Uniqsis Ltd. 

 

Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE